Brainsway Ltd
TASE:BWAY
Brainsway Ltd
Current Portion of Long-Term Debt
Brainsway Ltd
Current Portion of Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
B
|
Brainsway Ltd
TASE:BWAY
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Nano-X Imaging Ltd
NASDAQ:NNOX
|
Current Portion of Long-Term Debt
$3.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Inmode Ltd
NASDAQ:INMD
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Sisram Medical Ltd
HKEX:1696
|
Current Portion of Long-Term Debt
$9.8m
|
CAGR 3-Years
40%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
||
S
|
Sofwave Medical Ltd
TASE:SOFW
|
Current Portion of Long-Term Debt
$562k
|
CAGR 3-Years
141%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
E
|
Epitomee Medical Ltd
TASE:EPIT
|
Current Portion of Long-Term Debt
$449k
|
CAGR 3-Years
36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Brainsway Ltd
Glance View
Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.